Weight loss is not enough to treat dyslipidemia in women

Published Date: 06 Mar 2023

Obesity continues to exist around the world despite the risk to health and death from illness and disease.

Read Full News

Latest News

Where You Live May Shape Sleep Apnea Outcomes

Patients with obstructive sleep apnea who live in disadvantaged neighborhoods experience more severe sleep-related hypoxemia and have a higher risk for cardiovascular events.

CGM Looks Perfect. A1c Doesn't. Which One Is Right?

CGM and A1c increasingly disagree, especially with AID pumps. When should clinicians trust time in range over A1c? The evidence, the guideline gaps, and access disparities in type 1 and 2 diabetes.

Stroke Risk Peaks in the 3 Months After Cancer Diagnosis

The magnitude of the risk varies widely by cancer type, being highest for patients with lung or pancreatic cancers.

Routine Liver Markers May Signal Future Cardiovascular Risk

Elevated markers of liver fat, fibrosis, and functional decline are associated with an increased risk for cardiovascular disease in people without clinical liver disease at baseline.

Functional Angio Wins in Multivessel STEMI

Functional angiography is linked to a 38% lower risk for the primary outcome over conventional angiography in STEMI patients with multivessel disease.

Higher Hemoglobin May Promote Lower Mortality

Large cohort study shows sweet spot at 1-3 g/dL above the WHO threshold.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

Patients with obstructive sleep apnea who live in disadvantaged neighborhoods experience more severe sleep-related hypoxemia and have a higher risk for cardiovascular events.

CGM and A1c increasingly disagree, especially with AID pumps. When should clinicians trust time in range over A1c? The evidence, the guideline gaps, and access disparities in type 1 and 2 diabetes.

The magnitude of the risk varies widely by cancer type, being highest for patients with lung or pancreatic cancers.

Elevated markers of liver fat, fibrosis, and functional decline are associated with an increased risk for cardiovascular disease in people without clinical liver disease at baseline.

Functional angiography is linked to a 38% lower risk for the primary outcome over conventional angiography in STEMI patients with multivessel disease.

Large cohort study shows sweet spot at 1-3 g/dL above the WHO threshold.

News All Time

Gestational Age Predicts Neurodevelopmental Outcomes in CHD

Premature infants with congenital heart disease may have worse cognitive and motor development outcomes than those born at term, a cohort study shows.

PPIs: What Rigorous Data Actually Confirms

Ten PPI products share the same warnings on kidney disease, dementia, fracture, and cancer. Daniela Jodorkovsky, MD, on why study design keeps overturning the alarm.

Persistently High Troponin-T Levels in ACS Tied to HF Risk

Persistently elevated troponin-T levels are linked to a higher risk for heart failure in patients with suspected acute coronary syndrome, a study finds.

PARP Inhibitors: Narrower Labels, Wider Reach

Five branded products, four tumor types, and a regulatory arc that walked back late-line ovarian approvals even as AKEEGA just reached hormone-sensitive prostate cancer.

Response-Guided Therapy Trims Antibiotic Use in Endocarditis

Stopping antibiotics at clinical stabilisation in patients with left-sided endocarditis yields more days off therapy than standard regimens but is linked to a higher rate of relapse, a trial finds.

NICE Expands Drug Access for Young Children With NF1 Tumours

Trial data behind the decision showed durable tumour shrinkage and improved pain outcomes with mirdametinib, now recommended by NICE for children from age 2.

Cardiometabolic Risks Arise Early After Gestational Diabetes

Gestational diabetes is linked to an increased risk for type 2 diabetes and other cardiometabolic conditions within the first few years postpartum.

Cold Weather and Cardiovascular Risk: Does Climate Matter?

A large Brazilian study suggests colder temperatures may increase cardiovascular hospitalizations, while regional climate differences did not appear to change the association.

GLP-1s Tied to Metabolic Benefits in Rheumatology Patients

GLP-1 receptor agonists are linked to sustained weight loss, improved blood glucose and lipid measures, and reductions in certain inflammatory marker levels among patients with rheumatic diseases.

Top Psychiatric Predictors of CVD Risk After Trauma Revealed

A range of psychiatric conditions following trauma were tied to elevated cardiovascular risk, with alcohol use disorder emerging as the leading predictor in both men and women.

Exercise Cuts Arrhythmia Burden by 45% in AF

In the randomized NEXAF trial, a 1-year personalized exercise program reduced atrial fibrillation burden by 45% and lowered atrial fibrillation-related hospitalizations.

Med Op-Ed: Robot-Approved Refills, Ominous VTEs, and More

Prescription renewal systems raise liability and safety questions when clots may signal a catastrophic prognosis, and the merits of writing clinical notes.

Transportation Noise Tied to Stroke Recurrence Risk

Higher residential exposure to transportation noise was associated with increased odds of experiencing another stroke, a prospective cohort study shows.

Tricuspid Repair Cuts Death, HF Hospitalization in Severe TR

Transcatheter tricuspid valve repair added to medical therapy reduced clinical events in patients with severe tricuspid regurgitation, with marked reduction in HF hospitalization.

Aeson Artificial Heart Delivers in Advanced Heart Failure

Results presented at ESC 2026 and published in the European Heart Journal support the Aeson device as a potential option for patients with few remaining treatment alternatives.

Long-Term Primary Care Linked to Fewer Emergency Admissions

Findings suggest that maintaining stable primary care relationships may support earlier intervention and more efficient use of hospital services.

Recommended News For You

mRNA-based COVID vaccines generate improved responses to immunotherapy

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

Never in a million years did I think I'd have to limit my chemotherapy.

Recommended Articles For You

Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells 

Practical Practices in Oncology for Healthcare Excellence 

Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance 

Unlocking The Power Of Cangrelor To Treat Heart Disease 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

2.

Survivors of childhood brain cancer are more likely to be held back in school

3.

Abnormal Shadow on Chest Radiograph

4.

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

5.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

1.

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being

2.

Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches

3.

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer

4.

Rehabilitation Through Prehabilitation Before Complex Cancer Surgery

5.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Blood Clotting Disorders Explained

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

4.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

5.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot